Guidance for the management of hirsutism

References

• Ahmed B, Jaspan J. Hirsutism: a brief review. Am J Med Sci 1994;308:289–94
   PubMed Web of Science ®Google Scholar
• Harbourne L, Fleming R, Lyall H, et al. Hypertrichosis. J Am Acad Dermatol 2003;48:161–79
   PubMed Web of Science ®Google Scholar
• Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003;101:995–1007
   PubMed Web of Science ®Google Scholar
• Barth J, Catalan J, Cherry C, et al. Psychological morbidity in women referred for treatment of hirsutism. J Psychosom Res 1993;37:615–9
   PubMed Web of Science ®Google Scholar
• Fava G, Grandi S, Savron G, et al. Psychosomatic assessment of hirsute women. Psychother Psychosom 1989;51:96–100
   PubMed Web of Science ®Google Scholar
• Sonino N, Fava G, Mani E, et al. Quality of Life of hirsute women. Postgrad Med J 1993;69:186–9
   PubMed Web of Science ®Google Scholar
• Shenenberger D, Utecht L. Removal of unwanted facial hair. Am Fam Physician 2002;66:1907–11
   PubMed Web of Science ®Google Scholar
• Hamilton J. Male hormone is prerequisite and an incitant in common baldness. Am J Anat 1942;71:451–80
   Google Scholar
• Harborne L, Fleming R, Lyall H, et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:4116–23
   PubMed Web of Science ®Google Scholar
• Goodheart H. Hirsutism: Pathogenesis and Causes. Women’s Health Prim Care 2000;3:329–37
   Google Scholar
• MIMS May 2005. Available from www.emims.net [accessed 20 June 2005]
   Google Scholar
• Beigi A, Sobhi A, Zarrinkoub F. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Int J Gynaecol Obstet 2004;87:29–33
   Google Scholar
• Barth J, Cherry C, Wojnarowska F, et al. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study. Clin Endocrinol (Oxf) 1991;35:5–10
   PubMed Web of Science ®Google Scholar
• Dawber R, Van Neste D. Excess hair growth. In: Dawber R, Van Neste D, editors. Hair and Scalp Disorders. London: Martin Dunitz, 2004:186–9
   Google Scholar
• Guido M, Romualdi D, Giuliani M, et al. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological metabolic pilot study. J Clin Endocrinol Metab 2004;89:2817–23
   PubMed Web of Science ®Google Scholar
• Rittmaster R. Hirsutism. Lancet 1997;349:191–5
   PubMed Web of Science ®Google Scholar
• Venturoli S, Paradisi R, Bagnoli A, et al. Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism. Horm Res 2001;56:25–31
   PubMed Web of Science ®Google Scholar
• Camacho F. Drug treatment of hirsutism. In: Comancho F, Randall V, Price V, editors. Hair and Its Disorders Biology, Pathology and Management. London: Martin Dunitz Ltd, 2000:369–81
   Google Scholar
• Hunter M, Carek P. Evaluation and treatment of women with hirsutism. Am Fam Physician 2003;67:2565–72
   PubMed Web of Science ®Google Scholar
• Kelestimur F, Everest H, Unluhizarci K, et al. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism. Eur J Endocrinology 2004;150:351–4
   PubMed Web of Science ®Google Scholar
• Townsend K, Marlow K. Relative safety and efficacy of finasteride for treatment of hirsutism. Ann Pharmacother 2004;38:1070–3
   PubMed Web of Science ®Google Scholar
• Dierickx C. Hair removal by lasers and intense pulsed light sources. Semin Cutan Med Surg 2000;19:267–75
   PubMed Web of Science ®Google Scholar
• Tanzi E, Alster T. Long-pulsed 1064-nm Nd:YAG laser-assisted hair removal in all skin types. Dermatol Surg 2004;30:13–17
   PubMed Web of Science ®Google Scholar
• Handrick C, Alster S. Comparison of long-pulsed diode and long-pulsed alexandrite lasers for hair removal: a long-term clinical and histologic study. Dermatol Surg 2001;27:622–6
   PubMed Web of Science ®Google Scholar
• Kopera D. Hair reduction: 48 months of experience with 800 nm diode laser. Cosmet Laser Ther 2003;5:146–9
   PubMedGoogle Scholar
• Levy J, Trelles M, de Ramecourt A. Epilation with a long-pulse 1064 nm Nd:YAG laser in facial hirsutism. Cosmet Laser Ther 2001 2001;3: 175–9
   Google Scholar
• Clayton W, Lipton M, Elford J, et al. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005;152:986–92
   PubMed Web of Science ®Google Scholar
• Vaniqa Summary of Product Characteristics. Basingstoke: Shire Pharmaceuticals, 2004
   Google Scholar
• Barman Balfour J, McClellan K. Topical eflornithine. Am J Clin Dermatol 2001;2:197–201
   PubMedGoogle Scholar
• Schrode K, Huder F, Staszak J, et al. Evaluation of the long-term safety of eflornithine 15% cream in the treatment of women with excessive facial hair. Presented at 58th Annual Meeting of the Academy of Dermatology, San Francisco, 2000
   Google Scholar
• Huber F, Schrode K, Staszak J, et al. Outcome of a quality of life assessment used in clinical trials for hirsute women treated with topical eflornithine 15% cream. Presented at the 58th Annual Meeting of the Academy of Dermatology San Francisco 10–15 March, San Francisco, USA, 2000
   Google Scholar
• Huber F, Schrode K, Staszak J, et al. Use of a video imaging system to obtain hair measurement data in controlled clinical trials evalua ting the safety and efficacy of eflornithine 15% cream in the treat ment of excessive facial hair in women. Presented at 58th Annual Meeting of the Academy of Dermatology, San Francisco, 2000
   Google Scholar
• Piacquadio D, Smith S, Beger B, et al. A randomised, double-blind, vehicle-controlled, bilateral comparison study of the efficacy and safety of eflornithine cream (Vaniqa) in combination with laser in the treatment of unwanted facial hair in women. Presented at 61st Annual Meeting of the Academy of Dermatology, San Fransisco, USA, 2003
   Google Scholar
• Schrode K, Huder F, Staszak J, et al. Randomized, double-blind, vehicle-controlled safety and efficacy evaluation of eflornithine 15% cream in the treatment of women with excessive facial hair. Presented at 58th Annual Meeting of the Academy of Dermatology, San Francisco, 2000
   Google Scholar